This is not the most recent version of the article. View current version (8 JUL 2009)

Intervention Protocol

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

  1. Julia Bohlius1,*,
  2. Sven Trelle2,
  3. Olaf Weingart1,
  4. Guido Schwarzer3,
  5. Corinne Brillant1,
  6. Mike J Clarke4,
  7. Benjamin Djulbegovic5,
  8. Margret Piper6,
  9. Dirk Rades7,
  10. Jerome Seidenfeld6,
  11. Mark Somerfield8,
  12. David Steensma9,
  13. Martin Schumacher3,
  14. Andreas Engert1,
  15. Matthias Egger10

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 16 JUL 2008

DOI: 10.1002/14651858.CD007303

How to Cite

Bohlius J, Trelle S, Weingart O, Schwarzer G, Brillant C, Clarke MJ, Djulbegovic B, Piper M, Rades D, Seidenfeld J, Somerfield M, Steensma D, Schumacher M, Engert A, Egger M. Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD007303. DOI: 10.1002/14651858.CD007303.

Author Information

  1. 1

    University Hospital of Cologne, Cochrane Haematological Malignancies Group - Department of Internal Medicine 1, Cologne, Germany

  2. 2

    University of Bern, Division of Clinical Epidemiology and Biostatistics, Institute of Social and Preventive Medicine, Bern, Switzerland

  3. 3

    German Cochrane Center, Department of Medical Biometry and Statistics, Freiburg, Germany

  4. 4

    UK Cochrane Centre, Oxford, UK

  5. 5

    H. Lee Moffit Cancer Center & Research Institute, at the University of South Florida, Department of Oncology, Tampa, Florida, USA

  6. 6

    Blue Cross and Blue Shield Association, Technology Evaluation Center, Chicago, IL, USA

  7. 7

    University Hospital , Department of Radiation Oncology, Lübeck, Germany

  8. 8

    American Society of Clinical Oncology, Cancer Policy & Clinical Affairs, Alexandria , Virginia, USA

  9. 9

    Mayo Clinic, Rochester, MN, USA

  10. 10

    Institute of Social and Preventive Medicine, Department of Social Medicine, Bern, Switzerland

*Julia Bohlius, Cochrane Haematological Malignancies Group - Department of Internal Medicine 1, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50924, Germany. julia.bohlius@uk-koeln.de. jbohlius@ispm.unibe.ch.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 16 JUL 2008

SEARCH

This is not the most recent version of the article. View current version (08 JUL 2009)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.